Annual report pursuant to Section 13 and 15(d)

Stock Based Compensation (Details Textual)

v3.3.1.900
Stock Based Compensation (Details Textual) - USD ($)
12 Months Ended
May. 08, 2014
Dec. 31, 2015
Dec. 31, 2014
Aug. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common Stock, Capital Shares Reserved for Future Issuance       9,541,706
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum 4.00%      
Share-based Compensation Arrangement by Share-based Payment Award Increase of Shares Offering Date January 1, 2015      
Common Stock, Shares, Issued   57,180,148 32,292,650  
Share-based Compensation, Total   $ 1,592,367 $ 1,974,153  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value   $ 600,000    
Share-based Compensation Arrangement by Share-based Payment Award, Description   granted at prices not less than 100% of the fair value    
Employee Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Employee Service Share Based Compensation Total Compensation Cost Not Yet Recognized Stock Options Grants   $ 1,900,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term   1 year 3 months 18 days    
Board of Directors Chairman [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common Stock, Shares, Issued   278,784 292,650  
Share-based Compensation, Total   $ 200,000 $ 200,000  
Clinical Milestones [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares     71,750  
Share-based Compensation, Total     $ 28,000